REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 378.00
Bid: 0.00
Ask: 450.00
Change: 0.00 (0.00%)
Spread: 73.00 (19.363%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 378.00
BREE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

18 Nov 2020 07:00

RNS Number : 6378F
Breedon Group PLC
18 November 2020
 

NEWS RELEASE

 

18 November 2020

 

Breedon Group plc

("Breedon" or the "Group")

 

Trading Update

Breedon, a leading construction materials group in Great Britain and Ireland, today issues a scheduled Trading Update.

Trading performance

Breedon has continued to deliver an encouraging performance. The improving trends reported in our most recent trading update in September continued into the fourth quarter, with Group revenues in both September and October ahead of the same period in the prior year, on a like-for-like basis. As a result, the Group delivered revenues for the first 10 months of the year of £750 million (2019: £800 million), including three months contribution from the former CEMEX assets in the UK.

We welcome the various commitments made by UK and Irish governments to maintaining activity in the construction sector. We continue to operate our sites with a focus on the health and safety of all our colleagues, and expect limited impact from recently announced restrictions.

As a result, the Board now expects the Group's Underlying EBIT for the full year to be at least £70 million, which is ahead of current market expectations1.

Financial position

The combination of continued positive trading and our focus on cost control and prudent cash management, as well as the recently announced agreement to dispose of certain assets to Tillicoultry Quarries Limited (subject to final clearance by the CMA), means that we currently expect net debt to be below £400 million at the year end.

Outlook

Looking ahead, the ongoing COVID-19 pandemic and Brexit negotiations create continued economic uncertainty and result in limited visibility on trading conditions going into next year.

Nevertheless, with forecasters expecting a further recovery in construction activity in GB and Ireland in 2021 and the UK and Irish governments making significant commitments to infrastructure spending, the outlook for our markets remains encouraging. The Group will also benefit from the integration of the former CEMEX UK assets into its existing operations, along with initiatives to improve performance, anticipated to begin by the end of this year.

During 2020 we have proved our ability to deliver a resilient performance against a backdrop of unprecedented disruption, which gives us considerable confidence in the long-term outlook for our business.

We plan to announce our preliminary results for the year ended 31 December 2020 on 10 March 2021.

1 The Group believes that current market expectations for Underlying EBIT average £67 million for FY20.

- ends -

The information contained within this announcement is deemed by the Group to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014.

Information on Breedon Group

Breedon Group plc is a leading construction materials group in Great Britain and Ireland. It operates two cement plants and an extensive network of quarries, asphalt plants and ready-mixed concrete plants, together with slate production, concrete and clay products manufacturing, contract surfacing and highway maintenance operations. Following the acquisition of CEMEX's UK Assets (and subject to the remedies required by the CMA), the Group employs approximately 3,500 people and has around 1 billion tonnes of mineral reserves and resources. The Group's strategy is to continue growing through organic improvement and the acquisition of businesses in the heavyside construction materials market.

Enquiries:

Breedon Group plc

Pat Ward, Group Chief Executive

Rob Wood, Group Finance Director

Stephen Jacobs, Group Head of Communications

 

Cenkos Securities (NOMAD and Joint Broker to Breedon)

Max Hartley

Harry Hargreaves

 

Numis Securities (Joint Broker to Breedon)

Ben Stoop

Heraclis Economides

 

Teneo (Public Relations Adviser to Breedon)

Matt Denham

Rachel Miller

 

 

 

01332 694010

 

 

07831 764592

 

020 7397 8900

 

 

 

020 7260 1000

 

 

 

020 7420 3180

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBABRROUAAAA
Date   Source Headline
2nd May 20247:00 amRNSDirector/PDMR Shareholding
30th Apr 20243:06 pmRNSTotal Voting Rights
26th Apr 20243:39 pmRNSDirector/PDMR Shareholding
24th Apr 20244:40 pmRNSResult of AGM
24th Apr 20243:33 pmRNSDirector/PDMR Shareholding
24th Apr 20247:00 amRNSAGM Trading Update
5th Apr 20243:49 pmRNSDirector/PDMR Shareholding
4th Apr 20242:35 pmRNSDirector/PDMR Shareholding
28th Mar 20244:11 pmRNSTotal Voting Rights
18th Mar 202410:00 amRNS2023 Annual Report and Notice of AGM
12th Mar 20243:09 pmRNSApplication for Admission of Consideration Shares
7th Mar 20247:00 amRNSCompletion of Acquisition
6th Mar 20247:00 amRNSAcquisition
6th Mar 20247:00 amRNSFinal Results
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20243:51 pmRNSHolding(s) in Company
5th Feb 202410:00 amRNSNotice of Results
31st Jan 20249:18 amRNSTotal Voting Rights
29th Jan 20244:09 pmRNSHolding(s) in Company
29th Dec 20237:00 amRNSBlock listing six monthly return
29th Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSNovember Trading Statement
16th Nov 202310:07 amRNSDirector/PDMR Shareholding
8th Nov 20234:01 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
19th Oct 20231:59 pmRNSHolding(s) in Company
9th Oct 20232:24 pmRNSHolding(s) in Company
9th Oct 20232:23 pmRNSDirector/PDMR Shareholding
9th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 202310:53 amRNSDirector/PDMR Shareholding
9th Oct 202310:47 amRNSHolding(s) in Company
6th Oct 20235:15 pmRNSDirector/PDMR Shareholding
5th Oct 20235:32 pmRNSHolding(s) in Company
3rd Oct 20235:30 pmRNSIntention to acquire additional shares of Breedon
3rd Oct 20237:00 amRNSInvestor site visit
2nd Oct 202311:18 amRNSInterim Dividend Timetable
29th Sep 20239:37 amRNSTotal Voting Rights
31st Aug 202310:15 amRNSTotal Voting Rights
30th Aug 20235:02 pmRNSDirector/PDMR Shareholding
31st Jul 202311:36 amRNSTotal Voting Rights
26th Jul 20237:00 amRNSInterim results 2023
3rd Jul 20231:55 pmRNSNotice of Interim Results 2023
30th Jun 20239:55 amRNSTotal Voting Rights
27th Jun 202311:48 amRNSBlock Listing of Ordinary Shares
13th Jun 202310:51 amRNSReduction of Capital Effective
6th Jun 20235:02 pmRNSOutcome of Court Hearing on Reduction of Capital
2nd Jun 20233:25 pmRNSHolding(s) in Company
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.